The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: Clozapine versus classical antipsychotic agents

International Clinical Psychopharmacology

Volumn 14, Issue 4, 1999, Pages 229-232

  Spivak, B ^a,b   Musin, E ^a   Mester, R ^a,b   Gonen, N ^a,b   Talmon, Y ^c   Guy, N ^c   Roitman, S ^a   Kupchik, M ^a   Kotler, M ^d   Weizman, A ^b,e  

^a NESS ZIONA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c KAPLAN HOSPITAL   (Israel)

^d BEER YAAKOV MENTAL HEALTH CENTER   (Israel)

^e GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Body mass index; Classical antipsychotic agents; Clozapine; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; BODY WEIGHT; CHRONIC DISEASE; CLOZAPINE; FEMALE; HUMANS; MALE; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 0032773527     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199907000-00004     Document Type: Article

References (17)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
2. Botsaris SD, Sypek JM (1996) Weight gain associated with risperidone [letter]. J Clin Psychopharmacol 16:259.
3. Buchanan RW (1995) Clozapine: efficacy and safety. Schizophr Bull 21:579-591.
4. Bustillo JR, Buchanan RW, Irish D, Breier A (1996) Differential effect of clozapine on weight: a controlled study. Am J Psychiatry 153:817-819.
5. Casey DE (1996) Side effect profiles of new antipsychotic agents. J Clin Psychiatry 57 (Suppl. 11):40-45.
6. Cohen S, Chiles J, MacNaughton A (1990) Weight gain associated with clozapine. Am J Psychiatry 147:503-504.
7. Doss FW (1979) The effect of antipsychotic drugs on body weight: a retrospective review. J Clin Psychiatry 40:528-530.
8. Gerlach J (1991) New antipsychotics: classification, efficacy, and adverse effects. Schizophr Bull 17:289-303.
9. Kane JM, Honigfeld G, Singer G, Meltzer HY (1988) Clozapine or the treatment resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45;787-796.
10. Keks NA (1996) Minimizing the non-extrapyramidal side-effects of antipsychotics. Acta Psychiatr Scand 94:18-24.
11. Lamberti JS, Bellnier T, Schwarzkopf SB (1992) Weight gain among schizophrenic patients treated with clozapine. Am J Psychiatry 149:689-690.
12. Leadbetter R, Shutty M, Pavalonis D, Vieweg V, Higgins P, Downs M (1992) Clozapine-induced weight gain: prevalence and clinical relevance. Am J Psychiatry 149:68-72.
13. Safferman A, Lieberman JA, Kane JM, Szymanski S, Kinon B (1991) Update on the clinical efficacy 31SB03BK02.1V1 and side effects of clozapine. Schizophr Bull 17:247-258.
14. Silverstone T, Smith G, Goodal E (1988) Prevalence of obesity in patients receiving depot antipsychotics. Br J Psychiatry 153:214-217.
15. Stanton JM (1995) Weight gain associated with neuroleptic medication: a review. Schizophr Bull 21:463-472.
16. Stedman T, Welham J (1993) The distribution of adipose tissue in female in-patients receiving psychotropic drugs. Br J Psychiatry 162:249-250.
17. Umbricht D, Kane JM (1996) Medical complications of new antipsychotic drugs. Schizophr Bull 22:475-483.